Untangling the relationship between medication adherence and post-myocardial infarction outcomes: Medication adherence and clinical outcomes

American Heart Journal

Volumn 167, Issue 1, 2014, Pages

  Choudhry, Niteesh K ^a   Glynn, Robert J ^a   Avorn, Jerry ^a   Lee, Joy L ^a   Brennan, Troyen A ^c   Reisman, Lonny ^b   Toscano, Michele ^b   Levin, Raisa ^a   Matlin, Olga S ^c   Antman, Elliott M ^a   Shrank, William H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b AETNA   (United States)

^c CVS Caremark   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; ADVERSE OUTCOME; ARTICLE; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SECONDARY PREVENTION; SENSITIVITY ANALYSIS;

EID: 84890117796     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.09.014     Document Type: Article

References (24)

1. W.H. Shrank, M.E. Porter, and S.H. Jain A blueprint for pharmacy benefit managers to increase value Am J Manag Care 15 2 2009 87 93
2. J.A. Udell, M.A. Fischer, and M.A. Brookhart Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid J Bone Miner Res 21 5 2006 765 771
3. M.C. Roebuck, J.N. Liberman, and M. Gemmill-Toyama Medication adherence leads to lower health care use and costs despite increased drug spending Health Aff 30 1 2011 91 99
4. M.A. Brookhart, A.R. Patrick, and C. Dormuth Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect Am J Epidemiol 166 3 2007 348 354
5. J.N. Rasmussen, A. Chong, and D.A. Alter Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction JAMA 297 2 2007 177 186
6. C.R. Dormuth, A.R. Patrick, and W.H. Shrank Statin adherence and risk of accidents: a cautionary tale Circulation 119 15 2009 2051 2057
7. F.G. Kushner, M. Hand, and S.C. Smith Jr. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction and ACC/AHA/SCAI guidelines on percutaneous coronary intervention J Am Coll Cardiol 54 23 2009 2205 2241
8. N.K. Choudhry, M.A. Fischer, and J. Avorn The implications of therapeutic complexity on adherence to cardiovascular medications Arch Intern Med 171 9 2011 814 822
9. N.K. Choudhry, J. Avorn, and R.J. Glynn Full coverage for preventive medications after myocardial infarction N Engl J Med 365 22 2011 2088 2097
10. S. Karve, M.A. Cleves, and M. Helm An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients Med Care 46 11 2008 1125 1133
11. L.M. Hess, M.A. Raebel, and D.A. Conner Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures Ann Pharmacother 40 7-8 2006 1280 1288
12. J.F. Steiner, and A.V. Prochazka The assessment of refill compliance using pharmacy records: methods, validity, and applications J Clin Epidemiol 50 1 1997 105 116
13. D.C. Chan, W.H. Shrank, and D. Cutler Patient, physician, and payment predictors of statin adherence Med Care 48 3 2010 196 202
14. N.K. Choudhry, W.H. Shrank, and R.L. Levin Measuring concurrent adherence to multiple related medications Am J Manag Care 15 7 2009 457 464
15. J.V. Tu, P.C. Austin, and R. Walld Development and validation of the Ontario acute myocardial infarction mortality prediction rules J Am Coll Cardiol 37 4 2001 992 997
16. A. Kulik, J.P. Singh, and R. Levin Association between statin use and the incidence of atrial fibrillation following hospitalization for coronary artery disease Am J Cardiol 105 12 2010 1655 1660
17. D.Y. Lin, and L.J. Wei The robust inference for the Cox proportional hazards model J Am Stat Assoc 84 408 1989 1074 1078
18. E.S. Ford, U.A. Ajani, and J.B. Croft Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 23 2007 2388 2398
19. W.H. Shrank, N.K. Choudhry, and J.N. Liberman The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money Health Aff (Millwood) 30 7 2011 1351 1357
20. R.H. Chapman, J.S. Benner, and A.A. Petrilla Predictors of adherence with antihypertensive and lipid-lowering therapy Arch Intern Med 165 10 2005 1147 1152
21. N.K. Choudhry, S. Setoguchi, and R. Levin Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients Pharmacoepidemiol Drug Saf 17 12 2008 1189 1196
22. P.M. Ho, J.A. Spertus, and F.A. Masoudi Impact of medication therapy discontinuation on mortality after myocardial infarction Arch Intern Med 166 17 2006 1842 1847
23. S.W. Fletcher, F.A. Appel, and M.A. Bourgeois Management of hypertension. Effect of improving patient compliance for follow-up care JAMA 233 3 1975 242 244
24. S. Kripalani, X. Yao, and R.B. Haynes Interventions to enhance medication adherence in chronic medical conditions: a systematic review Arch Intern Med 167 6 2007 540 550